These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Immunologic response to cytomegalovirus infection in renal allograft recipients. Craighead JE Am J Epidemiol; 1969 Dec; 90(6):506-13. PubMed ID: 4312065 [No Abstract] [Full Text] [Related]
30. [Infections in renal transplant recipients in Norway]. Midtvedt K Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3621-3. PubMed ID: 10563182 [TBL] [Abstract][Full Text] [Related]
31. Reactivation of latent cytomegalovirus in allografts: comparison of lung graft and kidney graft in rats. Yagyu K; Takeshita M; Otsuka T; Kubota H; Furuse A; van Breda Vriesman PJ Transplant Proc; 1994 Aug; 26(4):2343-4. PubMed ID: 8066768 [No Abstract] [Full Text] [Related]
32. Prognostic effect of lymphocyte subgroup CD4+ and CD8+ cells in peripheral blood in renal transplant patients with cytomegalovirus viremia. Chen JS; Li LS; Cheng DR; Ji SM; Sun QQ; Cheng Z; Wen JQ; Sha GZ; Liu ZH Transplant Proc; 2009 Jun; 41(5):1639-42. PubMed ID: 19545698 [TBL] [Abstract][Full Text] [Related]
33. Is double renal transplantation a risk factor for cytomegalovirus disease? Moreno-Cuerda VJ; Aguado JM; Morales M; Andrés A; Morales JM; López-Medrano F; San Juan R; Lumbreras C Transplant Proc; 2005 Nov; 37(9):3764-5. PubMed ID: 16386531 [TBL] [Abstract][Full Text] [Related]
34. Myocarditis caused by cytomegalovirus infection in a child with a renal transplant. Bircan ZE; Buyan N; Olguntürk R; Söylemezoğlu O; Tunaoğlu S; Hasanoğlu E Nephrol Dial Transplant; 1994; 9(12):1803-4. PubMed ID: 7708269 [No Abstract] [Full Text] [Related]
35. The CARI guidelines. CMV disease and kidney transplant: prophylaxis for cytomegalovirus infection in patients following renal transplantation. Caring for Australians with Renal Impairment (CARI) Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S27-31. PubMed ID: 15469551 [No Abstract] [Full Text] [Related]
36. Letter: The transplanted kidney as a source of cytomegalovirus infection. Morris PJ; Oliver DO; Tobin JO N Engl J Med; 1976 Mar; 294(12):671-2. PubMed ID: 173993 [No Abstract] [Full Text] [Related]
37. Effects of cytomegalovirus infection on renal function in kidney transplant recipients. Choi SJ; Kim NH; Cho CK; Chung SY; Kim HJ; Choi KC; Kim SK Transplant Proc; 1996 Jun; 28(3):1523-4. PubMed ID: 8658769 [No Abstract] [Full Text] [Related]
38. [Acute cytomegalovirus pancreatitis with a favorable outcome in a renal transplant patient]. Mourad G; Levy G; Legendre C; Ruiz G; Bories P; Mion C Nouv Presse Med; 1982 May; 11(20):1571. PubMed ID: 6285283 [No Abstract] [Full Text] [Related]
39. Prophylaxis for cytomegalovirus in pancreas transplant recipients using intravenous ganciclovir. Kohli V; Velosa J; Sterioff S; Munn SR Transplant Proc; 1995 Dec; 27(6):2993. PubMed ID: 8539806 [No Abstract] [Full Text] [Related]
40. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation. San Juan R; Aguado JM; Lumbreras C; Fortun J; Muñoz P; Gavalda J; Lopez-Medrano F; Montejo M; Bou G; Blanes M; Ramos A; Moreno A; Torre-Cisneros J; Carratalá J; Clin Infect Dis; 2008 Oct; 47(7):875-82. PubMed ID: 18752439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]